2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Sales - EUR | 748.535 | 710.934 | 739.713 | 871.091 | 1.084.869 | 1.338.687 | 1.560.190 | 1.687.719 | 2.088.879 | 2.364.534 |
Total Income - EUR | 825.071 | 747.866 | 781.312 | 881.139 | 1.089.034 | 1.339.255 | 1.568.034 | 1.699.787 | 2.131.038 | 2.365.908 |
Total Expenses - EUR | 780.611 | 739.955 | 749.839 | 835.091 | 1.004.087 | 1.208.804 | 1.411.018 | 1.551.697 | 2.009.452 | 2.232.398 |
Gross Profit/Loss - EUR | 44.460 | 7.911 | 31.472 | 46.048 | 84.946 | 130.451 | 157.016 | 148.090 | 121.585 | 133.510 |
Net Profit/Loss - EUR | 37.610 | 4.241 | 25.966 | 36.744 | 72.605 | 111.278 | 134.942 | 125.540 | 104.448 | 112.877 |
Employees | 14 | 14 | 16 | 16 | 14 | 17 | 20 | 19 | 23 | 26 |
Check the financial reports for the company - Delpharma Srl
2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Fixed Assets | 95.582 | 78.653 | 73.034 | 90.177 | 99.129 | 94.996 | 97.050 | 100.692 | 151.589 | 135.732 |
Current Assets | 143.843 | 137.141 | 174.443 | 194.358 | 268.525 | 328.562 | 404.893 | 442.658 | 644.877 | 726.969 |
Inventories | 97.044 | 89.775 | 93.958 | 108.336 | 139.122 | 189.904 | 248.399 | 272.127 | 330.543 | 483.923 |
Receivables | 43.306 | 31.030 | 19.837 | 56.141 | 103.794 | 97.013 | 141.974 | 135.750 | 246.787 | 200.853 |
Cash | 3.492 | 16.336 | 60.649 | 29.881 | 25.610 | 41.645 | 14.520 | 34.780 | 67.547 | 42.193 |
Shareholders Funds | 120.028 | 125.272 | 54.920 | 97.850 | 157.466 | 163.629 | 186.301 | 175.759 | 154.823 | 163.100 |
Social Capital | 45 | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 |
Debts | 120.305 | 90.523 | 192.557 | 254.547 | 276.805 | 325.255 | 379.730 | 435.457 | 706.929 | 699.602 |
Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Exchange rate - RON | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 | 4.4821 |
Main CAEN | "4773 - 4773" | |||||||||
CAEN Financial Year |
4773
|
Subscriptions Financial Reports
You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.
Comments - Delpharma Srl